ZYLOX-TONBRDG.MED.TECH.H1 (818) — Defensive Interval Ratio
ZYLOX-TONBRDG.MED.TECH.H1 (818) has a Defensive Interval Ratio of 1302 days as of June 2025. Defensive assets of €1.15 Billion (cash €-, short-term investments €1.15 Billion, receivables €2.38 Million) cover 1302 days of daily cash needs of €885.01K/day. See ZYLOX-TONBRDG.MED.TECH.H1 short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
ZYLOX-TONBRDG.MED.TECH.H1 Defensive Interval Ratio (2021–2024)
This chart shows how ZYLOX-TONBRDG.MED.TECH.H1's Defensive Interval Ratio has evolved across 4 annual periods from 2021 to 2024. As of June 2025, the ratio stands at 1302 days, meaning defensive assets of €1.15 Billion can fund 1302 days of operations without new revenue. See ZYLOX-TONBRDG.MED.TECH.H1 balance sheet quality to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for ZYLOX-TONBRDG.MED.TECH.H1 (2021–2024)
The table below presents the year-by-year Defensive Interval Ratio for ZYLOX-TONBRDG.MED.TECH.H1 from 2021 to 2024, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see ZYLOX-TONBRDG.MED.TECH.H1 stock valuation.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 946 days | €866.32 Million | €915.53K/day | €- | €864.78 Million | ▲ +458 days |
| 2023 | 489 days | €425.47 Million | €870.64K/day | €- | €424.29 Million | ▼ -1087 days |
| 2022 | 1575 days | €656.38 Million | €416.67K/day | €- | €655.37 Million | ▼ -4104 days |
| 2021 | 5680 days | €1.51 Billion | €266.04K/day | €- | €1.51 Billion | — |